AHZ – Admedus on the mend? A chart review.

Buyers pushing share price higher.

Buyers pushing share price higher.

2015 has been a disappointing year for loyal shareholders in this biotech stock which has aspirations to expand its products globally.

Now at the end of the calendar year there is technical evidence of a change in trend following a 10 for 1 consolidation. The daily chart above shows an impulsive move higher taking the share-price from 65 cents to a high of 83 cents today (7 December). The share-price is now in an uptrend and gapped higher at today’s open.

Since the company is anticipating improving revenues and favourable news in 2016, investors will be looking for this gain to be maintained, although with the RSI now into overbought territory, a retracement is possible in the near future.

The next target for the share-price if the uptrend continues is the previous peak at 98 cents.

Categories: Chart Analyses, Technical Analysis

Tags: ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: